Literature DB >> 23787060

Attitudes towards psychiatric treatment and people with mental illness: changes over two decades.

Matthias C Angermeyer1, Herbert Matschinger, Georg Schomerus.   

Abstract

BACKGROUND: Over the past decades, psychiatry, as a science and a clinical discipline, has witnessed profound changes. AIMS: To examine whether these changes are reflected in changes in the public's conceptualisation of mental disorders, the acceptance of mental health treatment and attitudes towards people with mental illness.
METHOD: In 1990 and 2011, population surveys were conducted in Germany on public attitudes about schizophrenia, depression and alcohol dependence.
RESULTS: Although the public has become more inclined to endorse a biological causation of schizophrenia, the opposite trend was observed with the other two disorders. The public's readiness to recommend help-seeking from mental health professionals and using psychotherapy and psychotropic medication has increased considerably. Attitudes towards people with schizophrenia worsened, whereas for depression and alcohol dependence no or inconsistent changes were found.
CONCLUSIONS: The growing divide between attitudes towards schizophrenia and other mental disorders should be of particular concern to future anti-stigma campaigns.

Entities:  

Mesh:

Year:  2013        PMID: 23787060     DOI: 10.1192/bjp.bp.112.122978

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  58 in total

1.  Impact of the Germanwings plane crash on mental illness stigma: results from two population surveys in Germany before and after the incident.

Authors:  Georg Schomerus; Susanne Stolzenburg; Matthias C Angermeyer
Journal:  World Psychiatry       Date:  2015-10       Impact factor: 49.548

2.  [Should antipsychotics be used in prodromal stages of schizophrenia to prevent psychosis? Con].

Authors:  A Bechdolf; S Laier; M Kallenbach; A Biester; K Leopold
Journal:  Nervenarzt       Date:  2015-11       Impact factor: 1.214

3.  EPA guidance on improving the image of psychiatry.

Authors:  A M Möller-Leimkühler; H-J Möller; W Maier; W Gaebel; P Falkai
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2016-02-13       Impact factor: 5.270

Review 4.  Evidence-based psychotherapy for the prevention and treatment of first-episode psychosis.

Authors:  Hendrik Müller; Sonja Laier; Andreas Bechdolf
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-09-27       Impact factor: 5.270

5.  [Attitudes towards psychotherapy in South Korea and Germany : A cross-cultural comparative study].

Authors:  W Schulz; M A Shin; G Schmid-Ott
Journal:  Nervenarzt       Date:  2018-01       Impact factor: 1.214

6.  Approval of psychotherapy and medication for the treatment of mental disorders over the lifespan. An age period cohort analysis.

Authors:  S Van der Auwera; G Schomerus; S E Baumeister; H Matschinger; M Angermeyer
Journal:  Epidemiol Psychiatr Sci       Date:  2016-01-12       Impact factor: 6.892

7.  Public attitudes towards psychiatric medication: a comparison between United States and Germany.

Authors:  Georg Schomerus; Herbert Matschinger; Sebastian E Baumeister; Ramin Mojtabai; Matthias C Angermeyer
Journal:  World Psychiatry       Date:  2014-10       Impact factor: 49.548

8.  Attitudes towards the people with mental illness: comparison between Czech medical doctors and general population.

Authors:  Petr Winkler; Karolína Mladá; Miroslava Janoušková; Aneta Weissová; Eva Tušková; Ladislav Csémy; Sara Evans-Lacko
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2016-06-29       Impact factor: 4.328

9.  The differential effects of a focus on symptoms versus recovery in reducing stigma of schizophrenia.

Authors:  Ross M G Norman; Yixian Li; Richard Sorrentino; Elizabeth Hampson; Yang Ye
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2017-08-18       Impact factor: 4.328

Review 10.  State of the art of population-based attitude research on mental health: a systematic review.

Authors:  M C Angermeyer; G Schomerus
Journal:  Epidemiol Psychiatr Sci       Date:  2016-08-30       Impact factor: 6.892

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.